
Type 1 Diabetes
Latest News
Latest Videos

Shorts









More News

The FDA granted accelerated approval to teplizumab (Tzield) for children aged 8–17 with recently diagnosed stage 3 T1D, based on PROTECT phase 3 data.

New ADA 2026 analyses show Afrezza delivered comparable glycemic control, favorable safety, and higher treatment satisfaction in youth.

This decision marks the first FDA-approved inhaled insulin for pediatric patients.

A study found no association with prenatal antibiotic use and only a modest, potentially confounded increase in type 1 diabetes risk following early childhood exposure.

FDA approved insulin glargine-aldy as an interchangeable biosimilar to Lantus for type 1 diabetes and adult type 2 diabetes.

FDA expands teplizumab (Tzeld) use to children as young as 1 year with stage 2 type 1 diabetes, aiming to delay progression to clinical disease.

Get caught up with Contemporary Pediatrics. This list helps you navigate our top stories from the week, all in one place.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

A study found that dried blood spot screening can identify presymptomatic type 1 diabetes in children, reducing the risk of diabetic ketoacidosis.

With the priority review, the Prescription Drug User Fee Act date is set for April 29, 2026, for potential approval in this younger indication.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

Herbert Bravo, MD, and Marian Rewers, MD, PhD, explored how C-peptide preservation reshaped both clinical management and economic considerations in type 1 diabetes.

Clinicians reviewed evidence linking delayed diagnosis of type 1 diabetes to lasting neurologic and metabolic consequences.

Experts discussed how the 3-stage model reframed type 1 diabetes as a condition that could be detected through earlier screening.

This introductory Special Report episode outlines how advances in staging and early detection are reshaping pediatric approaches to type 1 diabetes.














